Alan Hoofring, John Boitnott, Michael Torbenson Journal of Hepatology

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Volume 32, Issue 2, Pages (February 2000)

The impact of hepatitis E in the liver transplant setting

Hepatic Disease of Horses in the Western United States

Volume 61, Issue 4, Pages (October 2014)

Volume 67, Issue 3, Pages (September 2017)

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

The role of Epstein–Barr virus in acute and chronic hepatitis

by Görgün Akpek, John K. Boitnott, Linda A. Lee, Jason P

Frank A. Anania, MD The American Journal of Medicine

Volume 39, Issue 4, Pages (October 2003)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

The impact of hepatitis E in the liver transplant setting

Fibrogenic impact of high serum glucose in chro nic hepatitis C

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

David G. Bowen, Christopher M. Walker Journal of Hepatology

The role of Epstein–Barr virus in acute and chronic hepatitis

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Volume 44, Issue 6, Pages (June 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Short-Bowel Syndrome Clinical Gastroenterology and Hepatology

Chronic HCV infection and the clonality of intrahepatic T cells

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Hepatitis C: global epidemiology and strategies for control

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Trends in the management and burden of alcoholic liver disease

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease Ferga C. Gleeson, Amy C. Clayton, Lizhi Zhang,

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

José Luis Lezana, Mario H. Vargas, José Karam-Bechara, Ruth S

De novo autoimmune hepatitis after liver transplantation

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg

Economics of chronic hepatitis B and hepatitis C

A.H. Gifford Journal of Cystic Fibrosis

Volume 39, Issue 3, Pages (September 2003)

Theresa Hydes, William Gilmore, Nick Sheron, Ian Gilmore

Liver stem cells and model systems for liver repopulation

Volume 50, Issue 4, Pages (April 2009)

News & Notes Journal of Allergy and Clinical Immunology

Paul C. Adams, James C. Barton Journal of Hepatology

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

Immigration and viral hepatitis

Alan Bonder, MD, Nezam H. Afdhal, MD

Volume 51, Issue 2, Pages (August 2009)

Position of the American Dietetic Association

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

The relationship between age and fat infiltration in liver and muscle

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

Presentation transcript:

Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection Alan Hoofring, John Boitnott, Michael Torbenson Journal of Hepatology Volume 39, Issue 5, Pages 738-741 (November 2003) DOI: 10.1016/S0168-8278(03)00413-6

Fig. 1 Hypothesized relationship between bridging fibrosis seen on tissue slides and actual three-dimensional characteristics of bridging fibrosis. Journal of Hepatology 2003 39, 738-741DOI: (10.1016/S0168-8278(03)00413-6)

Fig. 2 Two representative examples of three-dimensional reconstruction of bridging fibrosis (A,B). Insets show artist's (AH) reconstruction of the bridging fibrosis. Journal of Hepatology 2003 39, 738-741DOI: (10.1016/S0168-8278(03)00413-6)

Fig. 2 Two representative examples of three-dimensional reconstruction of bridging fibrosis (A,B). Insets show artist's (AH) reconstruction of the bridging fibrosis. Journal of Hepatology 2003 39, 738-741DOI: (10.1016/S0168-8278(03)00413-6)

Fig. 3 The relationship between the bile duct diameter and the fibrosis ratio (diameter of the portal tract/diameter of the bile duct). In the setting of no fibrosis (open circles) the ratio is fairly consistent for a range of bile duct diameters. In contrast, the case with portal and bridging fibrosis (dark circles) shows a distinct peak at about 18–19 μm in bile duct diameter. Journal of Hepatology 2003 39, 738-741DOI: (10.1016/S0168-8278(03)00413-6)